Last edition
News about "Glenmark Pharma to study potential Covid-19"
Glenmark Pharma to study potential Covid-19 drug combination
Glenmark Pharmaceuticals Ltd said on Tuesday it would begin a clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment
Glenmark Pharma To Study Potential Covid-19 | 26/05/2020 | By Darshana | 404
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members